类固醇诱发的骨质疏松优质PPT.ppt
《类固醇诱发的骨质疏松优质PPT.ppt》由会员分享,可在线阅读,更多相关《类固醇诱发的骨质疏松优质PPT.ppt(48页珍藏版)》请在冰豆网上搜索。
![类固醇诱发的骨质疏松优质PPT.ppt](https://file1.bdocx.com/fileroot1/2022-10/8/6f190363-9352-4d13-a5ac-c1e85c0e915b/6f190363-9352-4d13-a5ac-c1e85c0e915b1.gif)
Corticosteroid-InducedOsteoporosisCorticosteroid-InducedOsteoporosis20122012OsteoporosisSystemicskeletaldiseaseLowbonemassMicroarchitecturaldeteriorationofbonetissueIncreaseinbonefragilityandfracturesusceptibilityClinicalBurdenofCIOMostcommonformofdrug-relatedosteoporosisinmenandwomenOccursatanyage,inbothgenders,acrossracesUpto50%ofpatientsonchronicsteroidtherapysustainosteoporoticfracturesand/ordeveloposteonecrosisCorticosteroid-InducedOsteoporosisCommon,iatrogenicformofsecondaryosteoporosisAssociatedwithcorticosteroiduseinchronic,noninfectiousmedicalconditionsAsthma-NephroticsyndromeChroniclungdisease-TransplantationRheumatologicdisorders-etcInflammatoryboweldiseaseClinicalsignificant-Increasebonelossandfracture:
@#@6Mo.-Trabecularcorticalbone-7.5mgofprednisolone(equivalent)-Incidenceofosteoporosis30-50%-Vertebralfracture30-35%,hipfracture50%-Rateofboneloss2-4%peryear-Alternatedayregimen,inhalesteroidsFractureRiskandDoseofCorticosteroidsRelativeriskoffracturebydosagesofcorticosteroidsofprednisolone.vanStaaTP,etal,1998.01234562.5mg/d2.5-7.5mg/d7.5mg/dRelativeriskoffracturecomparedwithcontrolHipfractureVertebralfractureCIOinPatientsWithAsthmaRelationshipofpercentagepredictedbonedensitytodurationofcorticosteroidusein44corticosteroid-treatedasthmaticpatients.SchatzM,DudlJ,ZeigerRS,etal.AllergyProc.1993;@#@14:
@#@341-345.Reprintedwithpermission.Percentpredictedbonedensityr=-0.39(P=0.009)Durationofcorticosteroiduse(years)12010080604024681012141618202224262830323436CIOinPatientsWithRheumatoidArthritisCS=corticosteroid;@#@therapy=7mgprednisoneequivalentperday.DensitychangemeasuredaschangeinabsoluteorZscore(differenceinstandarddeviationcomparedwithhealthyage-matchedcontrolsofthesameraceandsex)comparedtobaseline.VerhoevenAC,etal,1997.*P0.001;@#@*P=0.002.PercentageofSLEpatients(N=97)withlowBMD,asmeasuredbyDXA.KipenY,etal,1997.CIOandSystemicLupusErythematosus*PotentialFactorsCausingBoneLossinInflammatoryBowelDiseaseCorticosteroidsVitaminD/CalciumdeficiencyPoornutritionalstatusInflammationPhysicalinactivityConcurrentmedications(immunosuppressiveagents)CIOandChronicObstructivePulmonaryDisease*P0.05vs.ISUorNSU;@#@*P0.005vsISU.McEvoyCE,etal,1998.*PathophysiologyofCIO:
@#@OverviewBoneremodelingoccursthroughoutadulthoodOsteoporosisresultsfromanimbalancebetweenosteoclastandosteoblastactivityTwometabolicabnormalitiescontributetoincreasedboneresorptionSecondaryhyperparathyroidismduetodecreasedGIabsorptionandurinaryexcretionofcalciumAlteredgonadalfunctionanddecreasedadrenalproductionofandrogensPathophysiologyofCIOCalciumhomeostasisGonadalhormoneInhibitboneformationIncreaseboneresorptionotherCalciumhomeostasisDecreasecalciumandphosphatefromGItractsunknownmechanismIncreaseurinarycalciumexcretiondecreasecalciumreabsorptionatdistaltubulesStimulatiomPTHsecretionGonadalhormoneeffectsDecreasesexhormone:
@#@direct&@#@indirectDecreaseLHfrompituitarygland:
@#@estrogenandtestosteroneDecreasesynthesisfromadrenalglandsDecreasesexhormonebindingglobulinBoneformationandboneresorptionOsteoblast-inh.Osteoblastproliferation-decreasematrixsynthesis-increaseapoptosis-decreaseproteinsynthesis(type1collagenandnoncollagenousprotein-decreaseosteocalcin,IGF1,IGFBP3,5,insulin-likegrowthfactors,transforminggrowthfactorB,prostaglandinEOsteoclastincreaseosteoclastactivityincreaseapoptosisofmatureosteoclastBoneformationandboneresorptionOsteoblastproliferationApoptosisOBnumberProteinsynthesisBoneformationDifferentiationBonemassFractureRiskAndrogenOsteoclastapoptosisBoneresorptionOsteoclastformationPTHCalciumandphosphateabsorption(gutandkidney)GlucocorticoidDiagnosisofCIO:
@#@InitialClinicalWork-UpMedicalhistoryRiskfactorsforbonelossPhysicalexamClinicalsignsandsymptomsPatientEvaluationHistoryDocumentationofheight,weight,musclestrength,balance,visionDocumentationofmedicalhistoryDocumentationofmenstrualhistory,infertilityinmenFracturehistoryandFamilyhistoryoffracturesOtherriskfactorsforosteoporosis:
@#@-Lifestylesinfluences:
@#@calciumandvitaminDintake,smoking,alcoholintake,medications,preventionoffalling-Patienteducation:
@#@preventionoffalling,exerciseGeneralhealthandprognosisPatientEvaluationPhysicalexaminationEvidenceofosteoporosis:
@#@evidenceoffracture,kyphosis,lossofheight,musclestrengthandsizeGeneralphysicalfindings:
@#@assessmentofunderlyingdisorder,othermedicalconditionsPatientEvaluationCompletebloodcountanderythrocytesedimentationrate(ESR)Serumcalcium,phosphate,creatinine,electrolyte,alkalinephosphatase,25-hydroxyvitaminD,estradiol,testosterone(male)24hr-UrinarycalciumandcreatinineBMDofspineandhipX-raysofappropriateareaslaboratory